GL1X · GenesisL1 explorer

Research workbench

Three dimensional structure of broadly neutralizing anti - hepatitis C virus (HCV) glycoprotein E2 alpaca nanobody D03

Analyse Three dimensional structure of broadly neutralizing anti - hepatitis C virus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4JVP
Type
protein
Length
258 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-HCV E2 alpaca nanobody D03
Ligands
SO4
Pockets
5 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAnti-HCV E2 alpaca nanobody D03protein1318% helix, 49% strand—
BAnti-HCV E2 alpaca nanobody D03protein1279% helix, 48% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 10 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.510.8516empty
21420.460.7720SO4
31100.440.7821SO4
41090.440.7823empty
5550.240.7215SO4

Interfaces

1 interface between chains.

  • A–B · 729 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4JVP · Three dimensional structure of broadly neutralizing anti - Hepatitis C virus (HCV)… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.